Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) with ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT)

Irwin Walker, Uday Deotare, Mohamed Elemary, Mahmoud Elsawy, Genevieve Gallagher, David Kliman, Tony Panzarella, Nada Hamad, Kirk R. Schultz, Jan Storek, Kristjan Paulson

Blood (2024) 144 (Supplement 1): 3519.

https://doi.org/10.1182/blood-2024-198798

Published: 2024

Journal Articles

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Michael D. Jain, MD PhD, Anca Prica, MD, Ryan D. Morin, PhD, Vishal Kukreti, MD, Robert Kridel, MDMPH,PhD, Rob C. Laister, PhD, Li Meng, Christopher Rushton, Miguel Alcaide, Rashmi S. Goswami, MD PhD, Jan Delabie, MD PhD, Jessica Weiss, Tony Panzarella, M.Sc., P.Stat, Michael Crump, MD, David W. Scott, MBChB, PhD, John Kuruvilla, MD

Blood (2019) 134 (Supplement_1): 2027.

https://doi.org/10.1182/blood-2019-131818

Published: 2019

Journal Articles

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Jean Roy, MD, Tony Panzarella, M.Sc., P.Stat, Stephen Couban, MDBSc, Félix Couture, MD FRCPC, Gerald M. Devins, PhD, Mohamed Elemary, MD, Stephen Ronan Foley, MD FRCPC, Genevieve Gallagher, MD, John Kuruvilla, MD, Stephanie J. Lee, MD MPH, John Moore, MDFRACP,FRCPA, Thomas J Nevill, MD, Gizelle Popradi, MD FRCP, Kirk R. Schultz, MD, David Szwajcer, MD FRCPC, Cynthia L Toze, MD FRCPC, Irwin Walker, MBBS, FRCPC

Blood (2019) 134 (Supplement_1): 875.

https://doi.org/10.1182/blood-2019-123275

Published: 2019

Journal Articles

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Michael D. Jain, MD PhD, Ryan D. Morin, PhD BSc, MSc, Anca Prica, MD, Vishal Kukreti, MD, Robert Kridel, PhD MD, Rob C. Laister, PhD, Li Meng, Christopher Rushton, BSc, Miguel Alcaide, PhD, Rashmi S. Goswami, BSc, MD PhD FRCPC, Jan M.A. Delabie, MD PhD, Jessica Weiss, Tony Panzarella, M.Sc., P.Stat, Michael Crump, MD, David W. Scott, PhD MD, FRACP, FRCPA, John Kuruvilla, MD

Blood (2018) 132 (Supplement 1): 4610.

https://doi.org/10.1182/blood-2018-99-117333

Published: 2018

Journal Articles

Management of Polycythemia Vera: a Survey of Canadian Physician Practice Plans

Laura Anne Habib, MD, Kevin H.M. Kuo, MD MSc, FRCPC, Tony Panzarella, M.Sc., P.Stat, Vikas Gupta, MD PhD, Martina Trinkaus, MD

Blood (2017) 130 (Supplement 1): 3382.

https://doi.org/10.1182/blood.V130.Suppl_1.3382.3382

Published: 2017

Journal Articles

Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy

Blood (2016) 128 (22): 4263.

https://doi.org/10.1182/blood.V128.22.4263.4263

Published: 2016

Journal Articles

Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)

Justyna Bartoszko, MD, Tony Panzarella, BSc MSc, Caroline Jane McNamara, MBBS, Anthea Lau, Aaron D. Schimmer, MD PhD, Andre C. Schuh, MD FRCPC, Hassan Sibai, MD, Karen W.L. Yee, MD, Mark D. Minden, MD PhD, Rebecca Devlin, PhD, Vikas Gupta, MD

Blood (2016) 128 (22): 4264.

https://doi.org/10.1182/blood.V128.22.4264.4264

Published: 2016

Journal Articles

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3 + NK cells

Blood (2016) 127 (24): 3082–3091.

https://doi.org/10.1182/blood-2015-09-668251

Published: 2016

Includes: Supplemental data

Journal Articles

Patient, Disease and Treatment Characteristics of Long-Term Survivors of Multiple Myeloma

Michael Kennah, MD, Nastaran Noroozi, MD FRCPC, Esther Masih-Khan, PhD, Tony Panzarella, M.Sc., P.Stat., Donna E Reece, MD FRCPC, Suzanne Trudel, MD, Vishal Kukreti, MD FRCPC, Rodger Tiedemann, MBChB, PhD, Christine I. Chen, MD MD FRCPC

Blood (2014) 124 (21): 2019.

https://doi.org/10.1182/blood.V124.21.2019.2019

Published: 2014

Journal Articles

The ASH Practice Improvement Module in Non-Hodgkin Lymphoma: Assessing the Feasibility, Reliability and Usefulness of a New Quality Improvement Tool

Michael D Jain, PhD MD, Lee Mozessohn, MD, Lauren M Gerard, MD, Jackie Ostro, MD, Mansoor Radwi, MD, Bertrand Routy, MD, Bethany Gill, BSc, MMath, Tony Panzarella, M.Sc., P.Stat., Peter Anglin, MD, Matthew C Cheung, Vishal Kukreti, Lisa Hicks, MD MSc

Blood (2014) 124 (21): 2651.

https://doi.org/10.1182/blood.V124.21.2651.2651

Published: 2014

Journal Articles

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

Irwin Walker, MBBS, Kirk R. Schultz, MD, Cynthia L. Toze, MD FRCPC, Holly Margaret Kerr, RN, BSN, John Moore, MD, David Szwajcer, MD FRCPC, Stephen Ronan Foley, MD FRCPC, John Kuruvilla, MD FRCPC, Tony Panzarella, M.Sc, Félix Couture, MD, Jean Roy, MD, Stephen Couban, MD FRCPC, Gerald Devins, PhD, Gizelle Popradi, FRCPC, MD, Stephanie J. Lee, MD MPH, Jason Tay, MD MSc, FRCPC, Thomas J. Nevill, MD FRCPC, Mohamed Elemary, MD MSc,PhD, Genevieve Gallagher, MD FRCPC

Blood (2014) 124 (21): 38.

https://doi.org/10.1182/blood.V124.21.38.38

Published: 2014

Journal Articles

A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies

Blood (2013) 122 (21): 709.

https://doi.org/10.1182/blood.V122.21.709.709

Published: 2013

Journal Articles

Higher Proportions of IFNg-Producing T Cells, CD56 bright NK Cells and Immature B Cells in the Lymphocytes of G-CSF Stimulated Donor Grafts Are Associated with Less Chronic Gvhd After HSCT: Results From the Canadian BMT Group 0601 Randomized, Phase III Trial

Sabine Ivison, PhD, Aminia Kariminia, PhD, Megan Levings, PhD, Raewyn Broady, MBChB, FRACP, Tony Panzarella, M.Sc., P.Stat., Alisha Albert-Green, MSc., Mahmoud Aljurf, M.D., Hind Al Humaidan, MD, FRCPA, Ronan Foley, MD, FRCPC, Gerald Devins, PhD, Holly Margaret Kerr, RN, BSN, Stephanie J Lee, MD, MPH, David Swajcer, MD, MPH, Cynthia L. Toze, MD, FRCP(C), Stephen Couban, M.D., Kirk R. Schultz, MD

Blood (2012) 120 (21): 1944.

https://doi.org/10.1182/blood.V120.21.1944.1944

Published: 2012

Journal Articles

Allogeneic Stem Cell Transplantation Is Associated with Long Term Disease Control in Chemo Sensitive Follicular Lymphoma Patients

Auro Viswabandya, MD, DM, Tony Panzarella, MSc, Dennis Dong Hwan Kim, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, PhD, John Kuruvilla, MD, FRCPC

Blood (2011) 118 (21): 2024.

https://doi.org/10.1182/blood.V118.21.2024.2024

Published: 2011

Journal Articles

Allogeneic Stem Cell Transplantation Is Associated with Prolonged Disease Control in Chemosensitive Aggressive Histology Lymphoma Patients When Done Early

Auro Viswabandya, MD, DM, Tony Panzarella, MSc, Dennis Dong Hwan Kim, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, PhD, John Kuruvilla, MD, FRCPC

Blood (2011) 118 (21): 4525.

https://doi.org/10.1182/blood.V118.21.4525.4525

Published: 2011

Journal Articles

Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma

Muhammad Ali, MD, Tal Schechter, MD, Tony Panzarella, MSc, Diego Villa, MD, MPH, John Kuruvilla, MD, Vishal Kukreti, MD, Richard Tsang, MD, John J Doyle, MD, Michael Crump, MD

Blood (2010) 116 (21): 2402.

https://doi.org/10.1182/blood.V116.21.2402.2402

Published: 2010

Journal Articles

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies

Stephen Couban, David R. Simpson, Michael J. Barnett, Christopher Bredeson, Lothar Hubesch, Kang Howson-Jan, Tsiporah B. Shore, Irwin R. Walker, Peter Browett, Hans A. Messner, Tony Panzarella, Jeffrey H. Lipton

Blood (2002) 100 (5): 1525–1531.

https://doi.org/10.1182/blood-2002-01-0048

Published: 2002

NARROW

A Randomized Pilot Trial Comparing Anti-Thymocyte Globulin (ATG) with ATG Plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis Against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT)

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma

Management of Polycythemia Vera: a Survey of Canadian Physician Practice Plans

Impact of Genomic Alterations on Outcomes in Myelofibrosis Patients Undergoing JAK1/2 Inhibitor Therapy

Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF)

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3 + NK cells

Patient, Disease and Treatment Characteristics of Long-Term Survivors of Multiple Myeloma

The ASH Practice Improvement Module in Non-Hodgkin Lymphoma: Assessing the Feasibility, Reliability and Usefulness of a New Quality Improvement Tool

Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial

A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies

Higher Proportions of IFNg-Producing T Cells, CD56 bright NK Cells and Immature B Cells in the Lymphocytes of G-CSF Stimulated Donor Grafts Are Associated with Less Chronic Gvhd After HSCT: Results From the Canadian BMT Group 0601 Randomized, Phase III Trial

Allogeneic Stem Cell Transplantation Is Associated with Long Term Disease Control in Chemo Sensitive Follicular Lymphoma Patients

Allogeneic Stem Cell Transplantation Is Associated with Prolonged Disease Control in Chemosensitive Aggressive Histology Lymphoma Patients When Done Early

Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only